March 24, 2020
Feline antiviral drug for FeLV, FIP is now being tested against SARS-CoV-2
A Singapore startup is testing its antiviral drug, RetroMAD1, against the SARS-CoV-2 beta-coronavirus that causes COVID-19. A spokesperson for Biovalence Technologies, the company that developed the drug, believes its drug could treat Covid-19.